Delivery Order SPE2DR25D3004-SPE2DR26FXTF6
- Not listed
- The Defense Logistics Agency awarded a $12,507.84 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of January 5, 2026, and represents a child order under a larger contract vehicle. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,822.46 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- The Defense Logistics Agency awarded a $7,245.84 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,299.76 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Vemlidy 25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,485.22 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is not set aside for any specific business category, is scheduled for completion by January 8, 2026, with fulfillment occurring at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $5,823.97 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units. The contract, awarded on November 7, 2025, with an ultimate completion date of November 10, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,873.72 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-unit package) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,359.25 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 19, 2025, with completion scheduled for December 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a direct supply transaction to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,018.04 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units at a firm fixed price ceiling value of $7,543.09. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is scheduled for ultimate completion on May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXTF6Delivery Order
The Defense Logistics Agency awarded a $3,126.96 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion deadline of January 9, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The award demonstrates the contractor's ongoing capability to fulfill federal pharmaceutical procurement requirements through open competition and reflects the critical role of pharmaceutical distributors in supporting the Defense Health Agency and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/7/26 |